Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06153108 · ClinicalTrials.gov registry record
Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time
A clinical trial of Inclusion Body Myositis, sponsored by University of Kansas Medical Center.
- Active
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT06153108: Active study of Inclusion Body Myositis, sponsored by University of Kansas Medical Center.
NCT06153108 is a study of Inclusion Body Myositis that is active but no longer recruiting, run by University of Kansas Medical Center. The registered enrollment target is 20 participants, below the 234-participant average among 10 other Inclusion Body Myositis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06153108, a study of Inclusion Body Myositis, is active but no longer recruiting, sponsored by University of Kansas Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Inclusion-Body Myositis (IBM) results in weakness and the deterioration of distal arm muscles, the symptoms of which are currently assessed through expert examination at clinical visits. Such in-clinic assessments are time-consuming, subjective, of limited sensitivity, and only provide a snapshot of a patient's disease. In this project, the investigators will conduct clinical validation of monitoring digital biomarkers of upper limb function during activities of daily living using a wearable sensor platform that enables frequent, at-home monitoring of upper limb function health in IBM and could be incorporated into IBM trials.
Primary Outcome
will investigate if sensor-derived parameters measured by the PAMSys wrist sensors and pendant sensor can quantify disease severity and track subtle changes in upper and lower limb health and ambulation over time.
Conditions Studied
Interventions
- DEVICE PAMSys pendant PAMSys wrist sensors
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-11-16 |
| Est. Completion | 2027-12 |
What the registry record for NCT06153108 still lists
NCT06153108 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 234-participant average among 10 other Inclusion Body Myositis trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Inclusion Body Myositis appearing as the primary indexed condition, and to 1 intervention - of which PAMSys pendant PAMSys wrist sensors is the first listed.
NCT06153108 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT06153108 about?
NCT06153108 is a clinical study titled "Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time". Inclusion-Body Myositis (IBM) results in weakness and the deterioration of distal arm muscles, the symptoms of which are currently assessed through expert examination at clinical visits. Such in-clinic assessments are time-consuming, subjective, of limited sensitivity, and only provide a snapshot of...
What is the current status of trial NCT06153108?
This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2023-11-16. Estimated completion is 2027-12.
What conditions does trial NCT06153108 study?
This clinical trial studies the following conditions: Inclusion Body Myositis.
What interventions are being tested in trial NCT06153108?
The interventions under investigation include: PAMSys pendant PAMSys wrist sensors (DEVICE).
Who is sponsoring clinical trial NCT06153108?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06153108 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inclusion Body Myositis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06153108's enrollment target sits among peer trials
20 7th of 10 higher than 2 of 10 other Inclusion Body Myositis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inclusion Body Myositis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Adult and Juvenile Myositis
RECRUITING
-
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
RECRUITING
-
Sporadic Inclusion Body Myositis Natural History Study
ACTIVE NOT RECRUITING
-
Phase III Trial of Sirolimus in IBM
ACTIVE NOT RECRUITING · Phase 3
-
Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI